Indol-2-one derivatives
    3.
    发明授权
    Indol-2-one derivatives 失效
    吲哚-2-酮衍生物

    公开(公告)号:US5773612A

    公开(公告)日:1998-06-30

    申请号:US640080

    申请日:1996-04-30

    摘要: A compound of formula II' ##STR1## in which R.sub.I is an ethoxy group or a chlorine atom; R.sub.II is hydrogen, a chlorine atom or a methyl group; R.sub.III is a chlorophenyl group or a methoxyphenyl group; R.sub.IV is an amino group, a group NR.sub.9 R.sub.10 or NR.sub.9 R.sub.XI, or a piperazin-1-yl radical substituted in the 4-position by a (C.sub.2 -C.sub.10)alkylene group substituted by an amino group which is free or carries a protective group; R.sub.10 is (CH.sub.2).sub.p R.sub.35 or a (C.sub.2 -C.sub.10)alkylene group substituted by R.sub.21 ; R.sub.XI is a (C.sub.1 -C.sub.12)alkyl group or a group .omega.-R.sub.32 R.sub.33 N(C.sub.1 -C.sub.4)-alkylcarbonyl; and R.sub.21 is R.sub.36 ; a group OR.sub.37 ; a group NR.sub.32 R.sub.33 ; a cyano group; a group S(C.sub.1 -C.sub.7)alkyl; a group SO(C.sub.1 -C.sub.7)alkyl; or a group SO.sub.2 (C.sub.1 -C.sub.7)alkyl; R.sub.35 is a piperid-4-yl group which is unsubstituted or substituted in the 1-position by a (C.sub.1 -C.sub.7)alkoxycarbonyl group or by a (C.sub.1 -C.sub.7)alkyl group; or a pyrid-2-yl group; R.sub.37 is R.sub.13 ; a (C.sub.3 -C.sub.7)cycloalkyl group; a (C.sub.1 -C.sub.6)alkylene group substituted by R.sub.24 ; a (C.sub.2 -C.sub.6)alkylene group substituted by a hydroxyl or a (C.sub.1 -C.sub.7)alkoxy group; or a (C.sub.2 -C.sub.6)alkylene group substituted by an amino group which is free or substituted by one or two (C.sub.1 -C.sub.7)alkyl groups or by a protective group; R.sub.24 is a carboxyl group; a (C.sub.1 -C.sub.7)alkoxycarbonyl group; a benzyloxycarbonyl group; or a carbamoyl group which is free or substituted by one or two (C.sub.1 -C.sub.7)alkyl groups.

    摘要翻译: 其中RI是乙氧基或氯原子的式II'化合物(II'); RII是氢,氯原子或甲基; RIII是氯苯基或甲氧基苯基; RIV是被无取代或携带保护基团的氨基取代的(C2-C10)亚烷基在4-位取代的氨基,NR9R10或NR9RXI基团或哌嗪-1-基; R 10为被R 21取代的(CH 2)p R 35或(C 2 -C 10)亚烷基; RXI是(C 1 -C 12)烷基或ω-R 32 R 33 N(C 1 -C 4) - 烷基羰基; R21为R36; 一组OR37; 一组NR32R33; 氰基; S(C 1 -C 7)烷基; SO(C 1 -C 7)烷基; 或基团SO 2(C 1 -C 7)烷基; R35是未被取代的或被(C1-C7)烷氧基羰基或(C1-C7)烷基取代在1位的哌啶-4-基; 或吡啶-2-基; R37是R13; (C 3 -C 7)环烷基; 被R24取代的(C1-C6)亚烷基; 被羟基或(C 1 -C 7)烷氧基取代的(C 2 -C 6)亚烷基; 或被一个或两个(C 1 -C 7)烷基或保护基取代的氨基取代的(C 2 -C 6)亚烷基; R24是羧基; (C1-C7)烷氧基羰基; 苄氧基羰基; 或不含或被一个或两个(C 1 -C 7)烷基取代的氨基甲酰基。